InvestSMART

Factor Therapeutics Limited (ASX: FTT) - Announcements

- Current share price for FTT : $0.005

ASX company news and announcements for Factor Therapeutics Limited (FTT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Factor Therapeutics Limited (FTT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Factor Therapeutics Limited (FTT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Factor Therapeutics Limited (FTT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 3B - lapse of unlisted share options 18 Feb 2019 8:31AM $0.003 $0.005 risen by 66.67%
- Shareholder Update 15 Feb 2019 10:52AM $0.003 $0.005 risen by 66.67%
- Cleansing Notice - issue of Placement Shares 11 Feb 2019 4:15PM $0.003 $0.005 risen by 66.67%
- Appendix 3B clarification - issue date of Placement Shares 8 Feb 2019 8:24AM $0.003 $0.005 risen by 66.67%
- TOV: Panel Receives Application 7 Feb 2019 3:29PM $0.003 $0.005 risen by 66.67%
- Change in substantial holding from PVD 6 Feb 2019 7:12PM $0.003 $0.005 risen by 66.67%
- Becoming a substantial holder 5 Feb 2019 12:26PM $0.003 $0.005 risen by 66.67%
- Additional placement details for issue of shares under LR71A 5 Feb 2019 9:41AM $0.004 $0.005 risen by 25%
- Cleansing Notice under s708A Corporations Act 5 Feb 2019 9:40AM $0.004 $0.005 risen by 25%
- Appendix 3B - placement shares 5 Feb 2019 9:39AM $0.004 $0.005 risen by 25%
- Placement completed to support future direction of Factor 5 Feb 2019 9:39AM $0.004 $0.005 risen by 25%
- Receipt of Notice under S249D Corporations Act 5 Feb 2019 9:38AM $0.004 $0.005 risen by 25%
- Update regarding anticipated R&D tax incentive rebate 4 Feb 2019 2:44PM $0.002 $0.005 risen by 150%
- Appendix 4C - December quarter 31 Jan 2019 8:36AM $0.002 $0.005 risen by 150%
- Management Change 25 Jan 2019 11:19AM $0.002 $0.005 risen by 150%
- Appendix 3Z - Dr Robert Ryan 12 Dec 2018 8:24AM $0.002 $0.005 risen by 150%
- Change to Board Composition 12 Dec 2018 8:23AM $0.002 $0.005 risen by 150%
- Shareholder Update - Frequently Asked Questions 22 Nov 2018 2:01PM $0.003 $0.005 risen by 100%
- Ceasing to be a substantial holder - Revised 21 Nov 2018 8:25AM $0.003 $0.005 risen by 66.67%
- Ceasing to be a substantial holder 20 Nov 2018 8:21AM $0.003 $0.005 risen by 66.67%
- Ceasing to be a substantial holder 16 Nov 2018 5:26PM $0.002 $0.005 risen by 150%
- Conference Call Details - Phase 2 Clinical Trial Results 14 Nov 2018 8:56AM $0.073 $0.005 fallen by 93.15%
- Results of Phase 2 Clinical Trial 14 Nov 2018 8:55AM $0.073 $0.005 fallen by 93.15%
- Trading Halt 13 Nov 2018 8:46AM $0.073 $0.005 fallen by 93.15%
- Appendix 4C - September 2018 Quarter 19 Oct 2018 1:41PM $0.075 $0.005 fallen by 93.33%

101 - 125 of 260 results

Page 5 of 11

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.